Analyst Defends USANA (USNA) as Shares Plunge: Upgrades to Buy
More News related to USNA
- USANA Health Sciences Launches Vitamin D Supplement
- USANA Supported Clinical Study Demonstrates Improved Bone Health in Girls
- Analyst Defends USANA (USNA) as Shares Plunge: Upgrades to Buy
- Morning Movers 10/28: CSBC, QTM, ANIK, RSYS, PEET, WSII Higher; CALC, KSP, PSYS, VCLK, VPHM, GT Lower
- USANA Health Sciences (USNA) Posts Q3 EPS of $0.51, Beats By 3c; Guides FY09
More News related to Upgrades
- Davenport Upgrades Heinz (HNZ) to Buy
- First Analysis Upgrades Advisory Board Company (ABCO) to Overweight
- Jefferies & Co Upgrades Energy XXI (EXXI) to Hold
- Morgan Stanley Upgrades Iowa Telecom (IWA) to Equalweight
- Fox-Pitt Upgrades Eaton Vance (EV) to Outperform
DA Davidson upgrades USANA Health Sciences (Nasdaq: USNA) from Neutral to Buy.
Shares of USANA have plummeted 14% today on the back of soft Q3 earnings reported last night. The stock most recently traded at $31.55.
To see all the market-moving upgrades/downgrades on shares of USANA, visit our Analyst Ratings page.
USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products.
Related Categories
UpgradesStocks Mentioned
-1.19Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
